A multiple-layer process for applying, in alternate, successive layers, the protein, avidin, and a biotin-containing extender material to a solid surface to modify the properties of the surface and to the multiple-layer product so prepared.
|
1. A process of modifying the surface properties of a surface, which process comprises:
applying alternative, monomolecular, successive layers of first and and second materials to a surface to be modified, the first material comprising avidin and the second material comprising a noncovalent, biotin-modified extender, one of the materials reacted to the surface, and, thereafter, at least one additional layer of each of the first and second materials alternated, secured and noncovalently reacted to the underlying layer, to provide a surface with the first or second material as the top surface layer thereon.
21. A monomolecular-layering process of modifying the surface properties of a substrate surface of a polymer, which process comprises:
(a) applying a layer of a biotin-N-hydroxysuccinimide ester as a biotin-extender material to the surface of a polymer, to react covalently the biotin-N-hydroxysuccinimide to the surface of the polymer; (b) washing the polymer surface to remove unreacted biotin-N-hydroxysuccinimide; (c) applying a layer of avidin to the washed polymer surface, to react noncovalently the avidin with the biotin-N-hydroxysuccinimide extender material; (d) washing the reacted surface to remove unreacted avidin; (e) applying to the washed avidin surface a noncovalent layer of a caproylamidobiotin nhs or rnase as a biotin-extender material; (f) washing the reacted surface to remove unreacted biotin-extender material; and (g) recovering the polymer having multiple layers, with the top layer composed of a biotin-extender material.
2. The process of
3. The process of
4. The process of
5. The process of
(a) applying a monomolecular layer of biotin and covalently binding the biotin to the surface; (b) applying and reacting a monomolecular layer of avidin to the biotin layer; and (c) applying and reacting a monomolecular layer of a biotin extender material to the avidin layer.
6. The process of
(a) applying another layer of avidin; and (b) applying another layer of the biotin extender material to the other layer of avidin.
7. The process of
8. The process of
9. The process of
10. The process of
12. The process of
14. The process of
16. The process of
17. The process of
18. The process of
22. The process of
(a) applying avidin to the washed polymer surface, to react another layer of avidin with the biotin-extender material; (b) washing the reacted surface to remove unreacted avidin; and (c) recovering a polymer having multiple layers, with the top layer composed of avidin.
23. The process of
25. The process of
|
of biotin-horse radish peroxidase (BHRPO) to each avidin layer treatment. The BHPRO served as a signal extender. Appropriate washing and control steps and treatment were carried out. The HRPO color at 500 nanometers was measured after each avidin layering step as a measure of the amount of avidin (most specifically, available avidin-binding sites for BHRPO), and the layering process was found to generate increasing amounts of avidin with each avidin layer (amplification layering), one of the three possibilities (constant, decreasing or increasing), cited earlier. The color-vs.-number-of-layers is as shown in Table 1.
TABLE I |
______________________________________ |
Absorbance 500 mm (color) vs. |
Number of Layering Cycles |
Absorbance |
No. of Layers Color Difference |
Avidin (n) Absorbance |
Values |
______________________________________ |
1 .746 |
2 .832 .086* |
3 .964 .132 |
4 1.124 .160 |
5 1.379 .255 |
______________________________________ |
*0.832 - 0.746 = 0.086 |
In order to illustrate more fully the nature of the invention and the manner of practicing the same, the following Example is presented:
PAC Materials1. Affigel-701 from Bio-Rad--an aminoethyl derivative of polyacrylamide in a bead form, 1-3 microns in diameter. The beads were provided in an aqueous suspension at 25±3 μ/mol of amine groups/ml.
2. Phosphate buffered saline (PBS)--an 0.01 M sodium phosphate, 0.15 M sodium chloride, pH 7.4.
3. Avidin--dissolved in PBS at 0.1 mg/ml based on weight.
4. Wash buffer--The buffer used for all washing steps was PBS containing bovine serum albumin (BSA) at 0.02% wt and Tween-20 surfactant at 0.05% wt.
5. HRPO substrate--was freshly prepared by dissolving phenol (100 mg) and 4-aminoantipyrine (16.2 mg) in a solution composed of 0.5 M Na2 HPO4 (2 ml), 0.5 M KH2 PO4 (18 ml), water (180 ml) and 30% H2 O2 (20 μl).
6. Silanized glass tubes--Disposable borosilicate glass tubes (12×75 mm) were silanized by filling with a 2% solution of chlorotrimethylsilane in benzene. The silanizing reagent was decanted after 1/2 hour, the tubes rinsed with acetone and air-dried.
7. Biotin NHS ester (biotin N-hydroxysuccinimide ester)--was prepared as defined in Jasiewicz, M. M., Schoenberg, D. R., and Mueller, G. C., Exp. Cell Res. 100, 213 (1978), hereby incorporated by reference.
8. Caproylamidobiotin-NHS and caproylamidobiotin-RNase (BRNase)--were prepared as defined previously (Costello, S. M. Felix, R. T. and Giese, R. W., Clin. Chem. 25, 1572 (1979), herein incorporated by reference).
9. BHRPO horse radish peroxidase (Worthington Biochemical)--10 mg were dissolved in 1 ml of water. This was added to a solution consisting of 1,6-hexanediamine (116 mg). 0.2 M sodium pyrophosphate (2.0 ml), water (5.0 ml) and sufficient concentrated HCl to bring the pH to 5.5. A solid water-soluble carbodiimide, 1-ethyl-3-(3-dimethylaminopyroyl) carbodiimide (EDC) was added to the gently mixed solution at room temperature. Three separate additions of 190 mg each were made over a 1-hour period. 11/2 hours after the first addition, the contents of the beaker were placed in a dialysis bag and dialyzed against 4×400 ml of PBS (pH=7.4). An aliquot (10 ml) from the dialysis bag was added to a solution of caproylamidobiotin-NHS ester (4.1 mg) in N,N-dimethylformamide (DMF) (0.1 ml). This solution was allowed to stand at room temperature for 11/2 hours and was then dialyzed against 4×400 ml of PBS (pH=7.4).
An aliquot (2 ml) of the above was placed in a dialysis bag and dialyzed against NaHCO3 (1 M) for 24 hours. The sample (at pH=8.6) was removed from the bag, placed in a small beaker with a magnetic mixer and reacted with 4 5×10 μl aliquots (15 minutes apart) of succinic anhydride (40 mg) in DMF (1 ml). The sample was placed in a dialysis bag 15 minutes after the last addition and dialyzed against 4×400 ml of PBS (pH=7.4).
Assuming 100% recovery of enzyme, the concentration of biotinyl-HRPO (BHRPO) would be approximately 0.8 mg/ml. It migrated electrophoretically (cellulose acetate, pH 8.6 buffer) in a manner similar to native enzyme (although the band was more diffuse).
10. Biotin-beads suspension--Affigel-701 (5.0 ml, about 125 μmol of amine groups) was added to PBS (5.0 ml). This suspension was vortexed 10 seconds, and biotin NHS ester (43 mg, 125 μmol) dissolved in DMF (0.1 ml) was added all at once. The reaction mixture was allowed to mix end over end for 2 hours at room temperature.
The beads were packed by centrifugation and the supernatant discarded. The bead pellet was resuspended in PBS and washed with 4×20 ml of PBS. The beads (biotin beads) were finally suspended in PBS (20 ml) containing NaN3 (0.02%).
Aliquots (50 ul) of biotin-bead suspension (magnetically mixing) were placed in 12×75 mm silanized glass tubes. Each tube was treated with avidin (0.1 mg in 1 ml PBS) for 10 minutes at room temperature. The beads were then centrifuged and the supernatants collected. The beads were washed X3 with wash buffer.
A layer was applied to the avidin-biotin beads by suspending them in 1 ml of caproylamidobiotin RNase (BRNase approximately 60 μg/ml) for 10 minutes. The beads were then spun and the supernatants collected. The beads were then washed X3 with wash buffer. The newly added biotin residues were next reacted with avidin as above. The sequence of avidin followed by BRNase, with intermittent washing steps, was repeated four more times. This process is set forth in FIG. 2.
Functional biotin binding sites on avidin-biotin beads (or layered beads) were detected by suspending aliquots of the beads after each avidin step in 200 μl of BHRPO (2 μg/ml) in PBS for 30 minutes. Unbound enzyme was removed by threefold washing with wash buffer. Bound enzyme was detected by addition of HRPO substrate (4.5 ml). After 30 minutes at room temperature, the tubes were chilled in an ice bath for 5 minutes and then spun. The supernatants were decanted and diluted with PBS (4.5 ml).
The A500 values of the diluted substrate solutions were measured on a Gilford 240 using water as a reference, and are given in Table I. As seen, the amount of functional enzyme on the beads is greater with each cycle of layering, and the rate of increase giving given by the difference values) also is increasing significantly as the layering proceeds; for example, the value 0.255 between layers 4 and 5 is 2.96 times greater than the value 0.086 between layers 1 and 2. This demonstrates the usefulness of layering for placing functional enzyme on a surface, increasing the amount of functional enzyme on a surface, and achieving an increasing rate of layering for the enzyme, that is, a relative increase in the amount of enzyme attached with each successive layer.
Avidin and some of the ligand binding proteins which may be employed in the practice of my invention are set forth in Table II.
TABLE II |
______________________________________ |
Avidin and Some Other |
Ligand-binding Proteins |
Usual No. |
Protein Ligand Affinity (Ka) |
of binding sites |
______________________________________ |
Lectins Simple sugars |
103 -104 |
4 |
membrane sites |
106 -107 |
Protein A Fc of IgG |
107 4 |
( S. aureus) |
Antibodies |
Haptens 105 -1011 |
2 |
Antigenic deter- |
105 -1011 |
2 |
minants |
Avidin Biotin 1015 4 |
Streptavidin |
Biotin -- 4 |
______________________________________ |
Patent | Priority | Assignee | Title |
10023895, | Mar 30 2015 | Accelerate Diagnostics, Inc. | Instrument and system for rapid microogranism identification and antimicrobial agent susceptibility testing |
10202597, | Mar 07 2011 | Accelerate Diagnostics, Inc. | Rapid cell purification systems |
10253355, | Mar 30 2015 | Accelerate Diagnostics, Inc. | Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing |
10254204, | Mar 07 2011 | ACCELERATE DIAGNOSTICS, INC | Membrane-assisted purification |
10273521, | Mar 30 2015 | Accelerate Diagnostics, Inc. | Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing |
10619180, | Mar 30 2015 | Accelerate Diagnostics, Inc. | Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing |
10669566, | Mar 30 2015 | Accelerate Giagnostics, Inc. | Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing |
11054420, | Jul 12 2003 | Accelerate Diagnostics, Inc. | Sensitive and rapid determination of antimicrobial susceptibility |
11603550, | Mar 15 2013 | Accelerate Diagnostics, Inc. | Rapid determination of microbial growth and antimicrobial susceptibility |
4685900, | Jun 01 1983 | KANEGAFUCHI CHEMICAL INDUSTRY CO , LTD , A CORP OF JAPAN | Therapeutic device |
4732811, | Feb 28 1982 | Yeda Research and Development Company, Ltd. | Agarose-polyaldehyde beads and their biological application affinity chromatography, hemoperfusion, cell separation, etc. |
4737544, | Aug 12 1982 | KANEGAFUCHI CHEMICAL INDUSTRY CO , LTD , A CORP OF JAPAN | Biospecific polymers |
4795459, | May 18 1987 | Rhode Island Hospital | Implantable prosthetic device with lectin linked endothelial cells |
5078673, | Nov 14 1988 | NEORX CORPORATION A CORPORATION OF WA | Selective removal of radiolabeled antibodies |
5180828, | Feb 09 1990 | MOLECULAR DEVICES, INC | Chromophoric reagents for incorporation of biotin or other haptens into macromolecules |
5374516, | Dec 18 1987 | Clinical Diagnostic Systems | Avidin-and biotin immobilized reagents and methods of use |
5472846, | Aug 18 1994 | Test kit and method for amplification and detection of antigen cells | |
5527711, | Dec 13 1993 | Agilent Technologies Inc | Method and reagents for binding chemical analytes to a substrate surface, and related analytical devices and diagnostic techniques |
5733254, | Oct 15 1987 | FRESENIUS HEMOCARE, INC | Method for treating patients suffering from immune thrombocytopenic purpura |
5958704, | Mar 12 1997 | ACCELERATE DIAGNOSTICS, INC | Sensing system for specific substance and molecule detection |
6033784, | Apr 03 1996 | Method of photochemical immobilization of ligands using quinones | |
6274384, | Mar 12 1997 | ACCELERATE DIAGNOSTICS, INC | Method for specific substance and molecule detection |
6287285, | Jan 30 1998 | Advanced Cardiovascular Systems, INC | Therapeutic, diagnostic, or hydrophilic coating for an intracorporeal medical device |
6531591, | Jul 07 1999 | Qiagen GmbH | Synthesis of stable quinone and photoreactive ketone phosphoramidite reagents for solid phase synthesis of photoreactive-oligomer conjugates |
6656517, | Jan 30 1998 | Advanced Cardiovascular Systems, Inc. | Therapeutic, diagnostic, or hydrophilic coating for an intracorporeal medical device |
8895255, | Jul 12 2003 | Accelerate Diagnostics, Inc. | Sensitive and rapid determination of antimicrobial susceptibility |
9434937, | Mar 07 2011 | ACCELERATE DIAGNOSTICS, INC | Rapid cell purification systems |
9657327, | Jul 12 2003 | Accelerate Diagnostics, Inc. | Rapid microbial detection and antimicrobial susceptibility testing |
9677109, | Mar 15 2013 | ACCELERATE DIAGNOSTICS, INC | Rapid determination of microbial growth and antimicrobial susceptibility |
9714420, | Mar 07 2011 | Accelerate Diagnostics, Inc. | Rapid cell purification systems |
9841422, | Jul 12 2003 | Accelerate Diagnostics, Inc. | Sensitive and rapid determination of antimicrobial susceptibility |
Patent | Priority | Assignee | Title |
4132528, | Jan 03 1978 | CLINICAL DIAGNOSTIC SYSTEMS INC | Analytical element for the analysis of liquids under high pH conditions |
4134792, | Dec 06 1976 | Miles Laboratories, Inc. | Specific binding assay with an enzyme modulator as a labeling substance |
4168300, | Jul 09 1975 | AB Kabi | Method of removal of hepatitis virus |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Date | Maintenance Fee Events |
Date | Maintenance Schedule |
Oct 23 1987 | 4 years fee payment window open |
Apr 23 1988 | 6 months grace period start (w surcharge) |
Oct 23 1988 | patent expiry (for year 4) |
Oct 23 1990 | 2 years to revive unintentionally abandoned end. (for year 4) |
Oct 23 1991 | 8 years fee payment window open |
Apr 23 1992 | 6 months grace period start (w surcharge) |
Oct 23 1992 | patent expiry (for year 8) |
Oct 23 1994 | 2 years to revive unintentionally abandoned end. (for year 8) |
Oct 23 1995 | 12 years fee payment window open |
Apr 23 1996 | 6 months grace period start (w surcharge) |
Oct 23 1996 | patent expiry (for year 12) |
Oct 23 1998 | 2 years to revive unintentionally abandoned end. (for year 12) |